Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Geron Corporation    GERN

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/13/2017 01/17/2017 01/18/2017 01/19/2017 01/20/2017 Date
2.11(c) 2.04(c) 2.06(c) 2(c) 1.99(c) Last
1 019 956 1 532 543 1 512 082 1 345 124 1 106 895 Volume
+0.96% -3.32% +0.98% -2.91% -0.50% Change
More quotes
Financials ($)
Sales 2016 4,21 M
EBIT 2016 -30,9 M
Net income 2016 -31,4 M
Debt 2016 -
Yield 2016 -
Sales 2017 25,9 M
EBIT 2017 -12,0 M
Net income 2017 -16,7 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 75,2x
Capi. / Sales2017 12,2x
Capitalization 317 M
More Financials
Company
Geron Corp. discovers and develops therapeutic products for cancer.It is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.Geron was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park,... 
More about the company
Surperformance© ratings of Geron Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on GERON CORPORATION
01/09 GERON CORP : Results of Operations and Financial Condition, Regulation FD Disclo..
2016 Geron Reports Imetelstat Presentations at American Society of Hematology Annu..
2016 GERON : Biotech Stocks Under Scanner -- Geron, Keryx Biopharma, Heat Biologics, ..
2016 GERON CORP : Other Events (form 8-K)
2016 Geron Announces November Investor Conference Presentation Webcasts
2016 ASH 2016 : Janssen to Present 43 Abstracts with Data on Ibrutinib, Daratumumab a..
2016 GERON : reports 3Q loss
2016 GERON CORP : Results of Operations and Financial Condition, Financial Statements..
2016 GERON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
2016 Geron Corporation Reports Third Quarter 2016 Financial Results and Recent Eve..
More news
Sector news : Bio Therapeutic Drugs
01/13DJNOVARTIS : Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs
01/12 Investors in big pharma, biotech look to ride out Trump storm
01/12DJHot Stocks to Watch in the U.S. and Canada
01/10 Regeneron CEO says Amgen not putting patients first in patent dispute
01/09DJCELGENE : Anticipates Slowing Sales Growth for Main Drug Revlimid
More sector news : Bio Therapeutic Drugs
Latest Tweets
01/1122 Stocks Moving In Wednesday's PreMarket  
01/10Get the latest news and updates for $TRVG $DTEGY $GERN $SMP $DMD automaticall.. 
01/03Nick's Picks: Beating The S&P 500 Soundly In 2016  
01/03Nick's Picks: Beating The S&P 500 Soundly In 2016
1
2016Want the latest upgrades & downgrades for $GERN $SMP $DMD $MCRI $WPC? Che.. 
More tweets
Qtime:51
News from SeekingAlpha
01/03 NICK'S PICKS : Beating The S&P 500 Soundly In 2016
2016 After Hours Gainers / Losers
2016 BACKTESTING 101, PART 4 : Frictional Costs, To Hedge Or Not To Hedge, And Benchm..
2016 Should Geron Opt-In?
2016 What Are The Actionable Takeaways From Geron's ASH Presentations?
Advertisement
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Technical analysis trends GERON CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 4,38 $
Spread / Average Target 120%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John A. Scarlett President, Chief Executive Officer & Director
Hoyoung Huh Chairman
Olivia K. Bloom Chief Financial Officer, Treasurer & Executive VP
Karin Eastham Independent Director
Robert Jay Spiegel Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GERON CORPORATION-3.86%317
AMGEN, INC.5.79%115 062
GILEAD SCIENCES, INC.-0.84%93 553
CELGENE CORPORATION-2.67%87 334
REGENERON PHARMACEUTIC..-1.23%38 239
ACTELION LTD4.58%23 977
More Results